不同MMR疫苗接种策略对江苏腮腺炎发病率的影响:基于18万病例的20年中断时间序列分析
本研究利用江苏省2005至2024年240个月法定传染病监测数据(183,490例),采用负二项分布广义线性模型的中断时间序列分析,评估1剂次与2剂次MMR疫苗接种策略对腮腺炎发病率的即时和长期影响。结果显示1剂次政策后无显著长期下降趋势,而2020年7月全面实施2剂次策略后,总体发病率呈每月1.0%的显著加速下降趋势,5-9岁和10-14岁年龄组下降最显著,≥15岁成人组也显示长期下降,提示群体免疫效应。
要点
- 1剂次MMR策略未能阻断腮腺炎3至5年的周期性流行。
- 2剂次MMR策略实施后,总体发病率呈每月1.0%的显著加速下降趋势。
- 5-9岁和10-14岁年龄组发病率下降最显著,≥15岁成人组也见群体免疫效应。
核心结论
- 1剂次MMR免疫程序不足以中断腮腺炎的周期性流行。
- 过渡到2剂次策略与江苏省总体腮腺炎发病率持续长期下降相关。
研究设计与样本
- 基于江苏省2005至2024年240个月法定传染病监测数据的中断时间序列分析,共纳入183,490例腮腺炎病例。
- 采用基于负二项分布的广义线性模型,并控制自回归、气象因素非线性效应、人口动态及COVID-19非药物干预强度。
主要发现
- 2008年引入1剂次MMR政策后,全省腮腺炎发病率无显著长期下降趋势(IRR=1.002,P=0.773),每3至5年的周期性暴发持续存在。
- 2020年7月全面实施2剂次MMR策略后,总体发病率呈每月1.0%的显著加速下降趋势(IRR=0.990,P=0.019)。
- 5-9岁和10-14岁年龄组发病率长期下降最显著,分别为每月1.0%和1.5%。
- 未直接接种疫苗的≥15岁成人组也显示长期下降(每月0.9%),提示显著的群体免疫效应。
- 2剂次政策成功缩小了地区发病率差异,显著减轻了2019年苏北观察到的补偿性暴发。
临床怎么用
- 支持继续和优化2剂次MMR免疫程序以控制腮腺炎流行。
- 在评估疫苗策略效果时,需考虑气象因素、人口动态及非药物干预等混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although China upgraded its mumps vaccine schedule to two doses, quantitative evaluations of real-world, population-level effects remain limited. This study systematically evaluated the immediate and long-term impacts of 1-dose and 2-dose measles-mumps-rubella (MMR) vaccination strategies on mumps incidence in Jiangsu Province. METHODS: Statutory infectious disease surveillance data spanning 240 months from 2005 to 2024 in Jiangsu Province (183,490 cases) were collected. An interrupted time series (ITS) analysis was conducted using a generalized linear model (GLM) based on a negative binomial distribution. We evaluated the intervention effects of the vaccine policies while strictly controlling for autoregression, non-linear effects of meteorological factors, population dynamics, and the intensity of COVID-19 non-pharmaceutical interventions (NPIs). Stratified analyses by age group and geographical region were also performed. RESULTS: Following the introduction of the 1-dose MMR policy in 2008, no significant long-term downward trend in mumps incidence was observed across the province (IRR = 1.002, P = 0.773), and periodic outbreaks every 3 to 5 years persisted. Following the comprehensive implementation of the 2-dose MMR strategy in July 2020, the overall incidence exhibited a significant accelerated downward trend of 1.0% per month (IRR = 0.990, P = 0.019). Subgroup analyses revealed that the most heavily burdened 5-9 and 10-14 age groups experienced the most significant long-term declines (1.0% and 1.5% per month, respectively). Furthermore, the ≥15 years adult group, which was not directly targeted for vaccination, also showed a long-term reduction (0.9% per month), indicating a significant herd immunity effect. Additionally, the 2-dose policy successfully smoothed out regional incidence disparities, notably mitigating the compensatory outbreaks observed in Northern Jiangsu in 2019. CONCLUSION: A 1-dose MMR immunization schedule is insufficient to interrupt periodic mumps outbreaks, and the transition to a 2-dose strategy was associated with a steady long-term decline in overall mumps incidence across Jiangsu Province, providing valuable real-world evidence to support the continuation and optimization of 2-dose MMR immunization schedules.
引用
- Li M, Yuan D, Wang Z, et al. Impact of different MMR vaccination strategies on mumps incidence in Jiangsu, China: A 20-year interrupted time series analysis based on 180,000 cases. Vaccine. 2026. PMID: 42743753. doi:10.1016/j.vaccine.2026.129156
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。